Amgen
AMGN
NZ$490.48
Share price
-0.70%
Change (1 day)
-0.47%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Amgen (AMGN) - Net assets
Net assets on the balance sheet as of March 2025 : NZ$10.31 Billion
According to Amgen's latest financial reports the company has NZ$10.31 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Amgen - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $NZ$10.42 B | 5.75% |
| 2023-12-31 | $NZ$9.85 B | 70.9% |
| 2022-12-31 | $NZ$5.76 B | -41.21% |
| 2021-12-31 | $NZ$9.80 B | -24.78% |
| 2020-12-31 | $NZ$13.04 B | -9.21% |
| 2019-12-31 | $NZ$14.36 B | -22.93% |
| 2018-12-31 | $NZ$18.63 B | -47.57% |
| 2017-12-31 | $NZ$35.54 B | -17.59% |
| 2016-12-31 | $NZ$43.12 B | 5.11% |
| 2015-12-31 | $NZ$41.03 B | 24.72% |
| 2014-12-31 | $NZ$32.90 B | 22.36% |
| 2013-12-31 | $NZ$26.88 B | 16.05% |
| 2012-12-31 | $NZ$23.16 B | -4.97% |
| 2011-12-31 | $NZ$24.38 B | -21.44% |
| 2010-12-31 | $NZ$31.03 B | -0.55% |
| 2009-12-31 | $NZ$31.20 B | -11.16% |
| 2008-12-31 | $NZ$35.12 B | 50.59% |
| 2007-12-31 | $NZ$23.32 B | -13.34% |
| 2006-12-31 | $NZ$26.91 B | -10.04% |
| 2005-12-31 | $NZ$29.92 B | 8.35% |
| 2004-12-31 | $NZ$27.61 B | -7.41% |
| 2003-12-31 | $NZ$29.82 B | -14.63% |
| 2002-12-31 | $NZ$34.94 B | 178.1% |
| 2001-12-31 | $NZ$12.56 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | NZ$150.58 B | 1,360.24% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$28.98 B | 181.10% | 🇺🇸 USA |
 GlaxoSmithKline GSK | NZ$29.35 B | 184.61% | 🇬🇧 UK |
 Gilead Sciences GILD | NZ$31.69 B | 207.36% | 🇺🇸 USA |
 Biogen BIIB | NZ$28.20 B | 173.54% | 🇺🇸 USA |
 AbbVie ABBV | NZ$2.42 B | -76.45% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$129.77 B | 1,158.40% | 🇺🇸 USA |
 Illumina ILMN | NZ$3.93 B | -61.85% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$26.32 B | 155.31% | 🇺🇸 USA |